Our Goal: Clinical Data, Faster

 

Presage's CIVO® platform accelerates early drug development by testing microdoses of anti-cancer agents directly in a patient's tumor.

Researcher
 

We believe the most important model for understanding cancer drug efficacy is the human body.

 
 

Read More

 

CIVO Platform

The patented CIVO platform is intended to evaluate early stage anti-cancer agents and combinations.

Learn More